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ABSTRACT
We recently reported the in vitro over-expression of 45A, a RNA polymerase III-
transcribed non-coding (nc)RNA, that perturbs the intracellular content of FE65L1 
affecting cell proliferation rate, short-term response to genotoxic stress, substrate 
adhesion capacity and, ultimately, increasing the tumorigenic potential of human 
neuroblastoma cells. In this work, to deeply explore the mechanism by which 45A 
ncRNA contributes to cancer development, we targeted in vitro and in vivo 45A levels 
by the stable overexpression of antisense 45A RNA.
45A downregulation leads to deep modifications of cytoskeleton organization, 
adhesion and migration of neuroblastoma cells. These effects are correlated with 
alterations in the expression of several genes including GTSE1 (G2 and S phase-
expressed-1), a crucial regulator of tumor cell migration and metastatic potential. 
Interestingly, the downregulation of 45A ncRNA strongly affects the in vivo tumorigenic 
potential of SKNBE2 neuroblastoma cells, increasing tumor nodule compactness and 
reducing GTSE1 protein expression in a subcutaneous neuroblastoma mouse model. 
Moreover, intracardiac injection of neuroblastoma cells showed that downregulation of 
45A ncRNA also influences tumor metastatic ability. In conclusion, our data highlight 
a key role of 45A ncRNA in cancer development and suggest that its modulation might 
represent a possible novel anticancer therapeutic approach.
INTRODUCTION
Non-coding (nc)RNA are widely recognized as 
crucial regulators of several physiological and pathological 
processes [1].
We recently reported that the expression of 45A [2], 
a pol III-transcribed ncRNA, perturbs the intracellular 
content of FE65L1 (APBB2, amyloid beta (Aβ) precursor 
protein-binding, family B, member 2, NP_004298.1), 
a protein potentially involved in the pathogenesis of 
Alzheimer disease (AD) due to its binding to amyloid 
precursor protein (APP, P05067) [3], [4]. Generation of 
the Aβ peptide and APP C-terminal fragment gamma 
are potentiated by the overexpression of FE65L1 and 
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decreased if an alternatively spliced, different form 
of the protein is synthesized [2]. Interestingly, in our 
studies we demonstrated that in neuroblastoma cells 
FE65L1 exerts a primary role in cell cycle regulation 
and genomic surveillances. Indeed, studying the effects 
of the 45A ncRNA overexpression on FE65L1 splicing 
and the consequent Aβ processing, we found, besides an 
altered amyloid release, an enhanced cell proliferation 
and, ultimately, an increase of the tumorigenic potential 
of tumor-derived cells. At the molecular level, this 
finding was supported by multiple evidences including 
the restriction of G2 and G2/M transition induced 
in 45A-overexpressing cells, the upregulation of 
different genes that promote cell proliferation (and the 
downregulation of those involved in differentiation and 
cell cycle arrest after DNA damage), and a short-term 
greater sensitivity to different genotoxic agents. Besides 
the increased tumorigenic potential in vitro, we also 
showed that 45A-overexpressing cells exhibit an enhanced 
potential to develop tumor in vivo, confirming the active 
role of 45A ncRNA in the determination of the malignant 
phenotype of NB cells [2].
Although in our previous work we showed that 45A 
ncRNA overexpression affects DNA damage response, 
cell proliferation and tumorigenesis [2], the mechanism 
by which this ncRNA contributes to tumor development 
still needs to be explored as 45A ncRNA targeting might 
constitute a novel approach to hinder tumorigenesis. In 
detail, our results were obtained using a highly malignant 
NB cell line and this might represent a potentially relevant 
model for the therapy of high risk NB.
NB is a pediatric tumor characterized by remarkable 
cellular heterogeneity. Among different NB stages, high 
risk NBs are characterized by poor prognosis and this 
cancer still accounts for about 15% of all pediatric cancer 
deaths [5].
In this work we explore the possibility to inhibit 
NB cell tumorigenic potential reducing the activity 
of 45A ncRNA in vitro and in vivo, through the stable 
overexpression of an anti-45A RNA. We show that deep 
modifications of cytoskeleton, cell adhesion and migration 
are induced after 45A downregulation. We demonstrate 
that this phenotype is consequent of altered expression 
of specific genes among which the downregulation of 
GTSE1 (G2 and S phase-expressed-1, NM_016426) 
plays a crucial role in the alteration of cell migration and, 
possibly, metastatic potential. Notably, we demonstrated 
that 45A ncRNA downregulation in malignant NB cells 
strongly affects tumor progression, increasing tumor 
nodule compactness and reducing GTSE1 protein 
expression (Q9NYZ3) in a mouse subcutaneous NB 
model. Interestingly, intracardiac injection of NB cells 
showed a peculiar tumor spreading indicating a key role 
for 45A ncRNA in the formation of metastasis. Therefore, 
our data suggest the possible control of 45A ncRNA 
expression as novel anticancer therapeutic approach.
RESULTS
The downregulation of 45A ncRNA synthesis 
impairs cell proliferation
In order to investigate the effects of 45A ncRNA 
downregulation on the NB tumorigenic potential, 
we first generated several clones of SKNBE2 cells 
permanently transfected with a plasmid harboring 45A 
RNA transcribed portion in antisense (AS) configuration, 
whose transcription is driven by its natural pol III type 
3 promoter. Among them, for the next experiment, we 
chose a SKNBE2 clone in which 45A ncRNA level was 
decreased by 73% (p<0.0001, Figure 1B). In particular, we 
compared the proliferation rate of this SKNBE2 Anti-45A 
clone, with Mock-transfected cells, by direct determination 
of population doubling time. We found that anti-45A RNA 
synthesis, and the consequent downregulation of 45A 
ncRNA, causes a significant increase of the population 
doubling time (p= 0.0266, Figure 1A).
In addition, we have detected an Anti45A-dependent 
decrease of cell proliferation rate in a non-Myc-N 
amplified neuroblastoma cell line, SH-SY5Y, evidencing 
that the results reported in this work can be obtained in 
different neuroblastoma cells (data not shown).
Thus, in agreement with the observation that 
the increased expression of 45A ncRNA promotes cell 
proliferation and increases tumorigenic potential, we show 
that the inhibition of its expression significantly limits the 
proliferation rate.
The silencing of 45A impacts on DNA damage 
response
We previously showed that the 45A expression 
significantly affects cell cycle progression after the 
exposure to different genotoxic agents, and confers 
a short-term sensitization toward doxorubicin and 
methylmethanesulfonate (MMS). However, compared to 
Mock cells, 45A-overexpressing cells did not accumulate 
a significant level of DNA damage, as determined by 
micronuclei and multinucleated cells induction [2].
In the light of these results, we investigated whether 
the delayed cell proliferation rate observed in Anti-45A 
expressing cells might affect the distribution among cell 
cycle phases, the accumulation of DNA damage, and cell 
survival following MMS treatment (Figure 2); to this aim, 
we used HEK-293-Anti45A and HEK-293-Mock cells 
as experimental model. Treatment with MMS affected 
the cell cycle progression in a dose-dependent manner 
in all the cells, although this effect was rather modest. 
However, comparing MMS effect in Anti-45A expressing 
and Mock cells, we observed that 0.05 mM MMS caused 
an increase in the percentage of Anti-45A cells entering 
in the S-phase, concomitantly with the decrease of the 
percentage of cells in G2/M. Conversely, the percentage of 
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G2/M cells slightly increased in Mock cells (Figure 2A). 
At 0.1 mM MMS, similar cell cycle profiles were found 
in both cell lines, suggesting that a higher level of MMS-
induced damage may trigger a different response, likely 
due to the activation of different DNA repair pathways. 
Nevertheless, the mitotic index was reduced following 
MMS treatment of Anti-45A cells, in agreement with a 
decreased G2/M fraction (Figure 2B).
The induction of DNA damage, detected as 
micronuclei (MN), fragmented nuclei (FR), and 
multinucleated cells (MultiN), was evaluated. While MN 
induction did not differ significantly between Mock and 
Anti45A expressing cells (Figure 2C), more FR nuclei 
at the lower 0.05 mM MMS concentration and a higher 
number of MultiN cells at 0.1 mM MMS were found 
in 45A-silenced compare to Mock cells (Figure 2C). 
Accordingly, the survival curve calculated following 
MMS exposure revealed a greater sensitivity of Anti45A 
cells than Mock at the 0.05 mM MMS (Figure 2D). 
A higher amount of MN, FR and MultiN cells in Anti-
45A compared to Mock cells were also found after UV 
exposure (Supplementary Data 1A); such an impaired 
processing of UV-induced DNA damage was reflected in 
a greater sensitivity of Anti-45A than Mock cells toward 
UV light (Supplementary Data 1B).
More FR nuclei at the lower 0.05 mM MMS 
concentration and a higher number of MultiN cells at 0.1 
mM MMS were found in 45A-silenced cells compared to 
Mock cells (Figure 2C). Accordingly, the survival curve 
calculated following MMS exposure revealed a greater 
sensitivity of Anti45A than Mock cells after treatment with 
0.05 mM MMS (Figure 2D).
Altogether these results indicate that the silencing 
of 45A ncRNA perturbs the progression through the cell 
cycle in the presence of DNA damage caused by MMS, 
a genotoxic agent able to trigger different DNA repair 
pathways such as the base excision repair (BER). Such a 
perturbation correlates with a higher burden of genomic 
damage.
The 45A ncRNA downregulation significantly 
affects the expression of cell division- and cell 
morphology-related genes
Since the downregulation of 45A ncRNA affects cell 
proliferation, we hypothesized that this phenomenon might 
Figure 1: The downregulation of 45A ncRNA delays cell proliferation and induces cytogenetic features changes. A. 
Population doubling time increased of SKNBE2 Mock and Anti45A permanently transfected cell lines. Results are normalized to Mock 
control. Data represent mean ± SD of 7 replicates (*p < 0.05). B. 45A (black bars) and GTSE1 (grey bars) expression level analyzed by Real-
Time RT-PCR in SKNBE2 cell lines. Data represent mean ± SD (**p < 0.01). C. 45A and GTSE1 expression level in different SKNBE2 cell 
clones permanently transfected with Anti-45A plasmid construct. D. 45A and GTSE1 expression level in Mock and 45A-overexpressing 
SKNBE2 cells.
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involve the modulation of the expression of genes involved 
in cell cycle control. To test this hypothesis, we measured 
the simultaneous expression of 84 genes involved in cell 
cycle control by cell cycle-specific Real-Time low density 
array (Human Cell Cycle RT2 Profiler TM PCR Array), using 
HEK-293-Anti45A and HEK-293-Mock cells. By arbitrarily 
imposing appropriate cut-off values (+35<y<+75.27 gene 
expression for the upregulated genes and -55.18<y<-1 
gene expression for downregulated genes), we found 5 
genes whose expression was significantly upregulated by 
45A ncRNA downregulation and only 1 (GTSE1) strongly 
downregulated (Figure 3A). This result was confirmed by 
Real-Time RT-PCR in SKNBE2 cells (GTSE1 expression 
was decreased by 50%, p=0.0011, Figure 1B) that showed 
a direct correlation between the expression level of 45A 
and GTSE1 (Figures 1B and 1C). To further strengthen 
the correlation between 45A/GTSE1 expression and to 
unequivocally demonstrate that the effects here observed in 
45A downregulated cells are not restricted to the SKNBE 
cell clone used, (and maybe due to a peculiar genomic 
integration site of the transgene that could lead to an 
idiosyncratic behaviour of this clone), we investigated the 
possible correlation of the expression level of 45A ncRNA 
and GTSE1 in 3 independent HEK-293 clones permanently 
transfected with Anti-45A ncRNA construct and expressing 
45AncRNA at different levels. As reported in Figure 1C, 
we demonstrated the strong correlation (Pearson correlation 
index r = 0.84) between the downregulation of 45A ncRNA 
and the decrease of GTSE1 expression. In addition, to 
further strengthen this correlation, we measured by Real-
Time RT-PCR 45A ncRNA and GTSE expression in Mock 
and 45A-overexpressing cells. The results showed that 
overexpression of this ncRNA leads to up-regulation of 
GTSE1 (Figure 1D).
Interestingly, we also observed in Anti-45a 
overexpressing cells the upregulation of a subset of genes 
involved in the maintenance of chromosome integrity 
and proper cell division in response to DNA damage 
(Supplementary Data 2). However, the remarkable 
downregulation of GTSE1 drew our attention as we found 
this gene significantly upregulated in 45A-overexpressing 
cells (data not shown). Interestingly, GTSE1 has been 
recently described as a microtubule protein involved in 
cell migration regulation and in metastasis [6], [7]. Thus, 
to corroborate Real-Time RT-PCR results, we performed 
immunofluorescence (IF) staining and Western blot 
analysis for GTSE1 in SKNBE2-Mock and SKNBE2 
Anti-45A cells, detecting a significant decrease of the 
cytoplasmic fraction of GTSE1 protein in SKNBE2 
Anti-45A compared to Mock cells (Figures 3B, 3C and 
Figure 2: The downregulation of 45A ncRNA impacts on DNA damage response. A. Distribution of HEK-293 Mock and 
Anti45A cell populations in cell cycle phases after MMS treatments and B. Mitotic Index representation. C. Evaluation of Micronuclei 
(MN), Fragmented cells (FR), Multinucleated cells (MultiN) and D. survival rate in HEK-293-Mock and HEK-293-Anti45A before and 
after MMS treatment. Data represent mean ± SD. One star (*) indicates p < 0.05, two-tailed Student’s test.
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3D). Therefore, these results suggest a link between an 
impairment of cell cycle progression driven by 45A 
ncRNA downregulation and specific changes of the 
cytoskeleton associated to this condition.
The inhibition of 45A affects cell morphology 
and migration potential
The induction of nuclear fragmentation and 
particularly of multinucleated cells drew our attention. 
Multinucleation, characterized by the accumulation 
of nuclei within the cytoplasm of a single cell, may result 
from defects involving centrosomes, spindle checkpoints 
or cytokinesis and can be associated with delay in cell 
cycle progression [8]. Thus, it is likely that the formation 
of multinucleated cells is due to an impaired expression 
of genes coding for components of the cytoskeleton [9]. 
The observation that Anti45A cells exhibit a peculiar 
morphology, not detected in Mock- or 45A-overexpressing 
cells, is in agreement with this hypothesis. As shown in 
Figure 3: The downregulation of 45A ncRNA modulates the expression of specific cell cycle related genes. A. Expression 
profile of genes involved in cell cycle progression and in cell cycle control in HEK-293-Anti45A/HEK-293-Mock cells; these genes 
have been considered arbitrarily imposing a cut-off (+35<up-regulated genes<+75.27 and -55.18<down-regulated genes<-1). B. 1-4: 
Representative GTSE1 IF on SKNBE2-Mock (CTR) (upper panels) and SKNBE2-Anti45A (lower panels). C. High magnification of single 
cell stained with Red-anti-GTSE1, Blue-Dapi and Green-GFP. D. GTSE1 Western blotting analysis of SKNBE2-Mock and SKNBE2-
Anti45A cells. Equal loading of proteins was ensured by β-actin expression. Cropped gel retains important bands of GSTE1 and β-actin.
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Figure 4A, colonies formed by HEK-293-Mock cells are 
rounded and poorly adherent whereas those originated 
by HEK-293-Anti-45A cells exhibit a spread, strongly 
adherent shape. As expected, once these cells were 
challenged by anti-tubulin IgGs, we found, at single 
cell level, remarkable differences of the cytoskeleton 
organization that confers the characteristic stretched form 
(Figure 4B). These observations suggest that Anti-45A 
cells might be particularly adherent due to specific changes 
at the level of cytoskeleton structure. To investigate cell 
adhesion properties, we seeded HEK-293-Anti-45A and 
HEK-293-Mock cells on uncoated dishes. After 3h we 
centrifuged the plates upside down and stained them 
with methylene blue. HEK-293-Anti-45A had a strongly 
Figure 4: Cell morphology and migration potential after inhibition of 45A ncRNA. A. Morphological analysis of colonies 
grown in adhesive condition of HEK-293-M and HEK-293-Anti45A cells. Right panels: GFP-positive colonies, as shown in the overlay 
picture. B. Morphological analysis of HEK-293-Mock and HEK-293-Anti45A permanently transfected cell lines, by ApoTome Microscope 
Technique from Carl Zeiss. Blue=DAPI, green=GFP, red=α-tubulin. C. Adhesion properties of HEK-293-Mock and HEK-293-Anti45A 
permanently transfected cell lines. Adherent cells were stained by methylene blue staining (right panel) and quantified by calculating 
the mean of cells counted in 3 independent wells (left panel). Data represent mean ± SD (*p < 0.05). D. Migration assay: using the 
xCELLigence RTCA DP Instrument (Roche), migratory capability of HEK-293-Mock and HEK-293-Anti45A cells has been quantified by 
the slope of the migration curve calculated by the RTCA 1.2 Software. Data represent mean ± SD (**p < 0.01). E. Wound healing assay: 
left panel shown quantitative analysis of open wound area percentage at different time point compared to T0 in HEK-293-Anti-45A and 
HEK-293-Mock cells; right panel shown representative image of open wound area (4x magnification). Results are representative for three 
independent experiments (mean ± SD, **p < 0.01). F. Capability of HEK-293 and G. SKNBE2 cells to form colonies in methylcellulose. 
Data represent mean ± SEM (*p < 0.05).
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adherent phenotype as their rate of detachment during 
centrifugation was significantly reduced as compared to 
the Mock cells (Figure 4C).
Next, we tested the influence of 45A downregulation 
on cell migration potential by two different approaches. 
By xCELLigence RTCA, a technology that allow the 
dynamic recording of the entire cell migration process 
in real time, we demonstrated that HEK-293-Anti-45A 
cellsshow a significantly increased migration than Mock 
cells (Figure 4D). This finding was further strengthening 
by a wound-healing assay, in which cells are allowed to fill 
the gap up to 24 h after seeding (Figure 4E). We observed 
an increased ability of HEK-293-Anti-45A to fill the 
wound, whereas HEK-293-Mock cells left a more open 
gap in the same time frame.
Considering that the overexpression of 45A ncRNA 
increases the tumorigenic potential of cancer cells and that 
its downregulation brings to an increased adhesiveness 
that, in principle, might be considered as decreased 
capability to growth in non-adherent conditions, we 
hypothesized that Anti-45A cells might exhibit a decreased 
tumorigenic potential. To verify our hypothesis, we tested 
the ability of the cells to form colonies in non-adhesive 
conditions (methylcellulose). We found that SKNBE2-
Anti45A cells are characterized by a reduced capability 
to form colonies in non-adhesive conditions (Figures 4F 
and 4G).
In conclusion, these data show that the 45A ncRNA 
downregulation confers the cell a less rounded shape 
more prone to adhere to the substrate and migrate, but 
less suitable to form colonies in methylcellulose, and thus 
possibly less efficient in the colonization of tissues and in 
the formation of metastasis.
The downregulation of 45A ncRNA expression 
affects cell stiffness
The altered ability to adhere to the substrate 
of 45A-downregulated cells, their altered migration 
properties, the peculiar shape of their colonies, together 
with the fact that they exhibit a downregulation of a 
cytoskeleton-associated protein, may suggest that 45A 
ncRNA is involved in the determination or maintenance 
of cell stiffness. In order to address this issue, indentation 
experiments were performed by atomic force microscopy 
(AFM) as described (see Materials and Methods). The 
Young’s modulus was calculated per each cell, mediating 
the values obtained by applying the Hertz’s contact theory 
on all the FI curves acquired on the single cell (1024 FI 
curves per cell). Figure 5A shows the average values of 
E (mean ± SD) for the different cell types (Anti45 n=22; 
Mock n=23) whereas the distributions of the mean values 
of E are reported in Figure 5B. The results obtained for 
both cell types were significantly different (p<0.05), 
demonstrating that a reduced activity of 45A ncRNA 
leads to a decreased stiffness and an increased flexibility 
of the cells. These results suggest a different behaviour 
of 45A-downregulated cells in metastatic colonization 
and are in agreements with previous findings obtained on 
different kinds of cancer cells [10]–[15].
Expression of Anti-45A slow down tumor growth 
in vivo
To assess whether 45A ncRNA downregulation 
affects tumor formation in vivo, we injected 
subcutaneously 3x106 Anti45A-overexpressing SKNBE2 
cells (and the correspondent Mock population) in a pool 
of 20 NOD-SCID mice, and evaluated possible differences 
of growth/tumor progression rate. As shown in Figure 6, 
40 days after the injection, 4/5 (80%) of the SKNBE2-
Mock-injected mice developed a tumour nodule ≥5 mm 
whereas only 2/5 (40%) of the SKNBE2-Anti45A-injected 
mice developed nodules. In addition, we observed a 
slight reduction of the average growing rate of nodules 
in SKNBE2-Anti45A- compared to the SKNBE2-Mock- 
injected mice (84 454 and 89 919 mm3/day, respectively; 
inset in Figure 6).
Therefore, these results suggest that the 45A ncRNA 
downregulation does not affect tumour initiation but rather 
impacts on the tumour growth rate.
The downregulation of 45A ncRNA leads to an 
increased compactness of tumor nodules and 
to reduced level of KI-67 and GTSE1 cancer 
markers
In the light of the significant variations of cell 
morphology, adhesion, migration and in vivo tumor 
growth ability, we postulated possible differences in the 
structural features of tumor nodules. In order to better 
identify the histological differences, we analyzed tumour 
nodules by Mallory’s trichrome staining, which evidence 
blue stromal tissue and red cellular components. The 
comparison of SKNBE2 histological sections showed 
that 45A downregulated nodules exhibited more compact 
collagen fibers resulting in a more evident cellular 
component than in Mock nodules. Differently, Mock 
tumor nodules showed the cellular component more 
dispersed in connective fibrous stroma, with a loss of the 
fibrous organization in which the cell elements are spread 
(Figures 7A and 7B). In agreement with this observation, 
the analysis of 45A ncRNA expression in the nodules, 
by Real-time RT-PCR, revealed an inverse correlation 
between the 45A ncRNA expression level and tumor 
nodules compactness (Figure 7A). Altogether these results 
are compatible with a peculiar intercellular adhesion by 
activation of specific genetic programs for cell-cell contact 
in 45A downregulated cells. Thus, we speculate that the 
downregulation of 45A ncRNA would reduce SKNBE2 
ability to escape from the primary tumor, leading to an 
altered potential to generate metastasis.
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Figure 5: Quantitative analysis of cell stiffness. A. Values of E calculated on Anti45A and Mock cells. Mock cells are significantly 
stiffer with respect to Anti 45 cells (*p<0.05). The error bars represent the standard deviation (SD) with respect to the mean value. B. 
Distributions of E calculated for Anti45 and Mock cells. Less than 15% of Anti45 cells have a Young’s modulus higher than 4.5 kPa (the 
gray vertical line is positioned at this value), while almost 50% of Mock cells are exceeding this value of E.
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Figure 6: Anti45A ncRNA expression decreases cancer progression in vivo. Tumor development function by the polynomial 
interpolation of SKNBE2 tumor nodules. The inset of the figure represents the linear regression of the averaged progression rate.
Figure 7: 45A ncRNA down-regulation increased tumor nodule compactness and collagen fibers organization. A. 
Representative light microscopy images of Mallory’s Trichrome stained section (10x magnification reconstruction and 40x magnification 
particulars) and 45a expression level determined by Real-Time RT-PCR in SKNBE2 tumor nodules. Data represent mean ± SD. 
The averaged results for each group are also reported in the inset (p=0.26). B. Representative images at high magnification of KI-67 
Immunohistochemical staining in SKNBE2-Anti45A and in SKNBE2-Mock tumour nodules sections. Lower panels are representative of 
negative control staining for KI-67 (CTR) (scale bar 100 μm). The quantification of KI-67 DAB positive cells in SKNBE2-Anti45A and 
SKNBE2-Mock tumour nodules sections is reported. Data represent mean ± SD (*p < 0.05). C. Representative images at high magnification 
of GTSE1 immunohistochemical staining in SKNBE2-Anti45A and in SKNBE2-Mock tumour nodules sections. Lower panels report the 
GTSE1 positive area selected from the above panel using ImageJ (scale bar 100 μm). The quantification of GTSE1 DAB positive cells in 
SKNBE2-Anti45A and SKNBE2-Mock tumour nodules sections is reported as average percentage from different mice (mean ± SD, **p 
< 0.01).
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Next we performed immunohistochemical analysis 
of KI-67 protein (P46013), a marker associated to cell 
proliferation. We found lower levels of KI-67 expression 
in tumor nodules obtained from mice injected with Anti-
45A cells (Figure 7B) (see also Supplementary Data 3). 
Notably, the amount of KI-67 positive cells in different 
mice correlated to the expression level of 45A ncRNA in 
the same tumour nodule (see Figure 7A). These results are 
in keeping with a reduced proliferation rate of cells from 
Anti45A tumor masses driven by a low expression of the 
ncRNA.
In the light of the increased compactness of Anti-
45A tumor nodules, we hypothesized a correlation 
between the level of GTSE1 protein and the invasiveness/
migration capability dependent on microtubule 
organization. To verify this hypothesis, we analyzed 
Figure 8: Effect of ncRNA on 45A down-regulation in an in vivo model of metastatic tumor. A. Left panel represent 
Bioluminescence analysis of mouse 30 days after injection of SKNBE2-Mock and SKNBE2-Anti45A cells line. On the right panel, 
bioluminescent assay (p/s) of tumor distribution at the same interval time is shown. Empty circle: SKNBE2-Mock cells lines; grey circle: 
SKNBE2-Anti45A cells lines. B. Several organs were analyzed for the different distribution of tumor metastasis. Graphics represent the 
percentages of metastasis generate from mice injected with SKNBE2-Mock and SKNBE2-Anti45A cells lines. Analysis was performed 
using 10 mice for each group. C. Histogram represents the percentages of metastasis found in lung or liver, respectively, in mice injected 
with SKNBE2-Mock and SKNBE2-Anti45A cells line. Right images acquired with IVIS instrument shows three representative mice per 
groups. Data represent mean ± SD (**p < 0.01). D. Twist and Vimentin expression levels analyzed by Real-Time RT-PCR in Mock and 
45A-downregulated cells. Data represent mean ± SD.
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GTSE1 protein level in tumor nodules from Mock and 
Anti-45A mice in immunohistochemistry experiments. 
We found that in Anti-45A tumour nodules GTSE1 
expression is significantly reduced with respect to Mock 
tumor nodules (Figure 7C) (see also Supplementary Data 
4, 5 and 6).
Since GTSE1 is an important player in cell 
migration and its dysregulation was associated with 
increased invasive potential in breast cancer [6], our 
results suggest a possible reduced aggressiveness or 
metastatic potential of 45A-downregulated cells pointing 
toward a putative anticancer activity of this ncRNA.
45A ncRNA plays a key role in the formation of 
metastasis
Besides our previous analysis of tumor nodules 
growth that took advantage of subcutaneously-injected 
mice xenografts, we decided to monitor in vivo the 
metastatic potential of 45A-downregulated nodules. To 
this aim, Mock and Anti45A-overexpressing cells were 
infected with a retroviral vector encoding the firefly 
luciferase gene to generate luciferase-positive cells. The 
development of metastasis and their growth rate were 
followed in the whole body using the IVIS technology. 
Thirty days after injection, total bioluminescence 
imaging (BLI) was lower in Anti-45A-injected mice as 
compared to control animals, even if the total number of 
metastasis was comparable in both groups (Figure 8A). 
Interestingly, after necroscopic analysis, we observed that 
mice injected with SKNBE2-Anti45A cells preferentially 
displayed metastasis within liver although, at a lesser 
extent, also lung, joints and lymph nodes were involved. 
On the contrary, mice treated with SKNBE2-Mock cells 
showed tumor spreading mainly in lung and lymph nodes 
and a minor contamination of liver and joints (Figures 
8B and 8C).
Altogether these results demonstrate that the 
downregulation of 45A ncRNA leads to a decreased 
metastatic potential in tumor cells and to their reduced 
possibility to engraft in lung and lymph nodes tissues, most 
likely due to the alteration of cytoskeleton and adhesiveness. 
This view is also supported by the downregulation of Twist 
and Vimentin in 45A-downregulated cells, as resulting by 
Real-Time RT-PCR determination, which indicates the loss 
of mesenchymal traits acquired by malignant cells during 
the Epithelial-Mesenchymal Transition (Figure 8D). This 
alteration might also render 45A downregulated cells 
particularly adapted to engraft the liver forming hepatic 
metastasis.
DISCUSSION
We recently reported the role of a pool of Pol III 
encoded ncRNAs as post-transcriptional regulators of 
several genes involved in both neurodegenerative and/
or proliferative pathological conditions [2], [16]–[23]. 
Particularly, we observed that the expression level of one 
of these ncRNA, named 45A, regulates the malignant 
potential of neuroblastoma cancer cells in vitro and in 
vivo driving to dramatic changes of cancer cell phenotype 
that strongly affect cell proliferation control, short-term 
response to genotoxic stress and substrate adhesion 
capacity [2].
In the present work, we investigated, in vitro and 
in vivo, the effects of a stable downregulation of 45A 
ncRNA on tumor formation ability of NB cells. Our 
results show that the reduced expression of this transcript 
strongly decreases cell capability to form colonies in 
non-adherent conditions. This behavior is associated 
to a delay in mitotic entry of cells that poorly express 
45A ncRNA, also demonstrated by an increased level 
of aneuploidy. Our data also show that the 45A ncRNA 
downregulation leads to a decreased cell survival 
consequent to an increased susceptibility to accumulate 
DNA damage. The characterization of this phenotype in 
vitro also evidenced remarkable changes in parameters 
associated to cytoskeleton structure that directly 
impact on carcinogenesis including cell morphology 
and migration potential as the downregulation of 45A 
ncRNA confers to the cell a less rounded shape (with 
a decreased stiffness and an increased flexibility) more 
prone to adhere to the substrate, less prone to migrate 
and less suitable to form colonies in methylcellulose, 
thus less efficient in the colonization of tissues and in the 
formation of metastasis.
These phenotypical traits are supported, at the 
genetic level, by the gene expression analysis, showing 
that a low expression of 45A ncRNA significantly affects 
the expression level of cell division- and morphology-
related genes. All these aspects are in agreement with the 
slow-down of the proliferation (documented also by the 
reduced KI-67 level) and the increased compactness of 
tumor nodules composed by Anti-45A-expressing cells, 
as observed in vivo.
Of particular interest is the decreased expression 
of GTSE1 driven by 45A-downregulation. Indeed, 
GTSE1 is a negative regulator of p53 that can shuttle 
between the cytoplasm and nucleus. After DNA 
damage, GTSE1 accumulates in the nucleus, where it 
interacts with p53 and shuttles it out of the nucleus to 
promote its downregulation and recovery from the p53-
induced G2 DNA damage checkpoint [24]. In addition, 
GTSE1 has been recently identified as microtubule-
associated +TIP protein required for EB1-dependent 
cell migration. It directly interacts with microtubules 
in interphase and is enriched at growing microtubule 
plus ends through interaction with EB1. In this context 
it is very interesting to note that a positive relationship 
between GTSE1 protein levels and cell migratory 
capacity has been reported [6]. It should be also noted 
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that GTSE1 is specifically expressed during S and G2 
phases of the cell cycle and mainly localized to the 
microtubules. Several experiments demonstrated that 
it plays a role in the control of G2/M transition and 
in the regulation of p53 function [25]. Therefore, the 
above data strengthened our hypothesis that the 45A 
ncRNA downregulation affects cell morphology and its 
adhesion capability restricting the tumorigenic potential 
of cancer cells.
Interestingly, these cell phenotype changes drive 
to an altered tumor formation potential in vitro and in 
vivo as Anti-45 ncRNA expression in SKNBE2 tumor 
cell line is associated to the reorganization of the 
stromal tissue component in tumor nodules compatible 
with an impairment of cell-to-cell contact, adhesion and/
or extracellular matrix deposition. Notably, the finding 
that the above mentioned phenotype changes can be 
observed also in a non-neuroblastoma cell suggests that 
the biological activity of 45A ncRNA is not restricted 
to this cell type. It is common knowledge that the 
fibrillar collagen network in tumor and normal tissues is 
different, due to remodeling of the extracellular matrix 
during the malignant character acquisition. In detail, 
normal tissues have more collagen than tumor tissues 
where a cap of collagen was observed at the periphery 
whereas within the tumor mass the distribution 
of collagen is heterogeneously spread [26]. In this 
context, our results suggest that the downregulation of 
45A ncRNA inhibits SKNBE2 tumorigenic potential in 
vivo.
The analysis of the tumors induced in vivo strengthen 
the view that 45A ncRNA affects the genetic program of 
cell-cell contacts being 45A-downregulated nodules more 
compact, less proliferating and poorly expressing GTSE1, 
a panel of characteristics that, altogether, strongly support 
a different ability to metastasize. This is also shown by 
the distribution of the metastatic nodules shown by the 
Anti45A-injected mice. Thus, the deep investigation of the 
mechanisms that make 45A-downregulated cells prone to 
colonize the liver might disclose novel hints in the field of 
metastatization.
In conclusion, this work demonstrates that 
the expression level of 45A ncRNA influences the 
compactness of tumor nodules, their capability to colonize 
different tissues forming metastasis thus deserving further 
investigations with possible prognostic and/or therapeutic 
significance.
MATERIALS AND METHODS
Cell culture and transfection
HEK-293 (Human Embryonic Kidney) were 
maintained on Dulbecco’s modified Eagles medium 
(DMEM, ECB7501L, EuroClone, Milan, Italy), 10% 
FBS (DE14-801F, Lonza, Milan, Italy), L-Glutamine 
(2 mM; EuroClone), and penicillin–streptomycin (100 
U/ml/ 100 μg/ml; EuroClone). SKNBE2 (Human 
Neuroblastoma) cells were maintained on RPMI 1640 
medium (ECB9006L, EuroClone), 10% FBS (DE14-801F, 
Lonza), L-glutamine (2 mM; EuroClone), penicillin–
streptomycin (100 U/ml/ 100 μg/ml; EuroClone) 
(standard medium). HEK-293 cells were transfected 
using polyethylenimine (PEI; P3143, Sigma-Aldrich, 
Milan, Italy), SKNBE2 cells by a Microporator MP-100 
(Digital Bio; NanoEnTek, Seoul, Korea; Labtech France) 
with pEGFP-N1 (Clontech, USA; restriction site used for 
molecular cloning procedures: AseI) as control (hereafter 
referred to as Mock) and pEGFP-N1-Anti-45A (hereafter 
referred to as Anti-45A). G418 (Geneticin; Invitrogen, 
Carlsbad, CA, USA) was used in culture medium as mean 
of selection up to 1 000 μg/ml, until resistant cells were 
identified. After selection, the cells were preserved in 200 
μg/ml G-418 in standard culture conditions. The sequence 










Retrovirus production and infection
Retroviruses were prepared by calcium phosphate 
co-transfection of HEK-293 T cells mixing the 
retroviral expression vector pL-Luc-IH, encoding the 
firefly luciferase gene linked by a IRES sequence to 
the hygromycin resistance (Hygro R) gene [27], with 
the packaging vector pkat2ampac [28]. The retrovirus-
containing supernatant was harvested 48 h post-
transfection and used to infect target cells in the presence 
of 8 μg/mL Polybrene (Sigma-Aldrich). After 48 h, the 
transduced cell lines were selected with Hygromycin B 
100 μg/mL (Sigma-Aldrich).
Real time quantitative RT-PCR analysis
Total RNAs from samples were extracted using 
TRIzol reagent (Invitrogen) according to the manufacturer’s 
protocol, DNAseI-digested and subjected to reverse 
transcription by Transcriptor High Fidelity cDNA 
Synthesis Kit (05081955001, Roche, Germany) following 
manufacturer’s instructions. The total RNA from samples 
was measured by quantitative RT-PCR Real-Time using PE 
ABI PRISM@ 7700 Sequence Detection System (Perkin 
Elmer Corp./Applied Biosystems, Foster City, CA) and 
Sybr Green method following manufacturer’s instructions. 
The sequences of forward and reverse primers were: 
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45A: 5’-CATCTATAATGGCTGAATTGGAA-3’ and 
5’-ATGAACTTTCCAACAAATGTTGTT-3’; GTSE1: 
5’-GCCACATGCTGGGGATGTGC-3’ and 5’-GCCCC 
GGGTGCTGTCAATGT-3’. For endogenous control, 
the expression of Glyceraldehyde 3 phosphate 
dehydrogenase (GAPDH) was examined. The 
sequences for human GAPDH primers were 
5'-GAAGGTGAAGGTCGGAGTC-3' and 5'-GAAGA 
TGGTGATGGGATTTC-3'. Relative transcript levels were 
determined from the relative standard curve constructed from 
stock cDNA dilutions, and divided by the target quantity of 
the calibrator following manufacturer's instructions.
Cell proliferation assays
For cell counting studies, cells were seeded at 1.5 x 
105 cells in 6 well plates, incubated in standard medium 
and counted with a hemocytometer after 48 hours.
Cell cycle analysis
The cell cycle was analyzed after 70/30% ethanol/
water fixation permeabilization with 1% Nonidet P-40 
(Sigma-Aldrich) and labeling with propidium iodide 
(PI; Sigma-Aldrich). Samples were run on a FACSort 
cytofluorimeter (Becton Dickinson, Palo Alto, CA, USA), 
and cell cycle analysis was performed by the ModFit LT 
3.0 computer program (Verity Software House, Topsham, 
ME, USA).
cDNA synthesis and real time-PCR array
The cDNA for each RNA sample was obtained 
using RT2 First Strand kit (SABiosciences Corporation, 
QIAGEN Company, Frederick, MD) according to the 
manufacturer’s instructions. Briefly, after genomic 
DNA elimination, the reverse transcription reaction was 
performed at 42°C for 15 min and then heated at 95°C for 
5 min to inactivate the enzyme. The cDNA was mixed with 
RT2 SYBR green/ROX qPCR master mix (SABiosciences 
Corporation) and 25 μl aliquots were loaded into each 
well of the RT2 Profiler PCR Array (Cat. No. PAHS-
020, SABiosciences Corporation). The PCR array was 
designed to study the profile of 84 human cell-cycle-
related genes. PCR array experiments were performed 
on an Eppendorf Realplex4 epgradient S Mastercycler®. 
Conditions for amplification were as follows: 1 cycle of 
10 min at 95°C followed by 40 cycles of 15 s at 95°C and 
1 min at 60°C. The PCR array data were analyzed by PCR 
Array Data Analysis web-based software (SABiosciences 
Corporation).
Colony forming assay
Cells were seeded at 400 cells in 60 mm dish, 3 
dishes per dose, for the determination of cell survival 
measured as colony forming ability. After 8–10 days, the 
dishes were fixed and colonies counted.
MN assay
The day before treatment, cells were seeded in 35-
mm dishes coverslips. Cells were cultured at densities 
of 3x105 cells/coverslip, using conditions ensuring 
that cells were actively growing after 1 h treatment 
MMS, depending from the intensity of the lamp. At the 
appropriate harvest time, cells were rinsed and exposed 
to a hypotonic shock in situ using Iskandar solution 
(0.9% NaCl/75 mM KCl; 9:1). Cells were then fixed with 
MeOH/HOAc (3:1) and stained with Giemsa. All slides 
including those of positive and solvent controls were 
coded before analysis and scored blindly for the evaluation 
of MN by two independent observers. The criteria used 
for identifying MN fulfil those recommended by the 
HUMNwork [25]: (1) area <1/3 the main nucleus area; (2) 
no overlapping with the nucleus (distinct borders); and (3) 
same aspect as the chromatin. MMS was tested at doses 
0.05 mM and 0.1 mM; UV doses were 5 J/m2 and 10 J/m2.
Methylcellulose colony formation assay
Clonogenic assay was performed using a 
methylcellulose medium consisting of RPMI 1640 with 
0.9% methylcellulose (Methocult H4100; StemCell 
Technologies, Vancouver, BC, Canada), 10% FBS, 100 U/
ml penicillin/streptomycin and 2 mM L-glutamine. Cells 
were plated at a density of 400 cells in 2 ml volume of 
methylcellulose medium in humidified 6-well plates. For 
each assay, cells were plated in triplicate. Colonies were 
counted at 14 days after plating.
Cell migration assay
Cell migration was analysed by the technique of 
real-time migration monitoring using the CIM-Plate 16 
and xCELLigence System RTCA DP Instrument (Roche). 
The day before migration assay, cells were plated in 
starvation medium (medium with FBS 0.5%). After 
24 hr, 4x104 cells, resuspended in 100 μl of serum-free 
medium, were seeded in the upper chamber of a CIM-
Plate 16. The upper chamber was then placed on the lower 
chamber of the CIM-Plate 16 containing growth medium 
supplemented with 20% FBS as an attractant, or without 
FBS (negative control). Time-dependent cell migration 
was monitored over a period of up to 60 hours, and 
experimental results were analyzed using RTCA Software 
1.2 considering the interval of 0-6 hours.
Cell adhesion assay
This protocol was adapted from Mc Clay et al., 1981 
[29]. Cells were plated at 1.5x105 cells/well in a 24-well 
tissue culture plate; 3 h after cell plating, the multi-well 
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plate was centrifuged twice in inverted position (well 
bottom placed up in a swing-out rotor) at 1 000 rpm for 30 
s. The cells still adherent to the wells were then fixed in 
3.7% paraformaldehyde in PBS, stained with methylene 
blue and counted (each well was divided in quadrants and 
3 quadrants/well were counted). Each value represents the 
mean ± SD of three independent wells.
Monolayer wound healing assay
Cells were grown to full confluence in 6-well 
plates in their growth media and were scratched with a 1 
000 μL sterile pipette tip. Medium was change to remove 
detached cells and six pictures for well were acquired 
at 4x magnification after 24, 48 and 72 hours, using 
an EVOS fl Digital Inverted Fluorescence Microscope 
(Advanced Microscopy Group, WA, USA). The open 
wound area (24 h, relative to 0 h values) was quantified 
with TScratch software. Data represent mean ± SEM of 
6 replicates. Results are representative for 3 independent 
experiments.
Western blot
Western blotting was performed with a SDS-PAGE 
Electrophoresis System as described previously [30]. 
Briefly, protein samples were electrophoresed on 12.5% 
polyacrylamide gels under reducing conditions; blotted 
to nitrocellulose membrane; and sequentially probed with 
antibodies. The antibodies used were: rabbit polyclonal 
anti-GTSE1 (ab103232, Abcam, Cambridge, UK), mouse 
monoclonal anti-β-Actin antibody (A5441, Sigma-
Aldrich), anti-rabbit IgG (A0545, Sigma-Aldrich), anti-
mouse IgG (A0168, Sigma-Aldrich). The densitometric 
analysis of protein bands was performed using the ImageJ 
software system.
Ethics statement
Investigation has been conducted in accordance with 
the ethical standards. The care and the use of the animals 
were in compliance with laws of the Italian Ministry of 
Health and the guidelines of the European Community. 
All experiments involving animals were reviewed and 
approved by the licensing and ethical committee of the 
AUO San Martino IST, Genoa, Italy, and by the Italian 
Ministry of Health. Efforts were made to minimize animal 
stress/discomfort.
In vivo tumorigenicity assay
Homozygous NOD-SCID (NOD.CB17-Prkdcscid) 
mice were purchased from the Jackson Laboratory (Bar 
Harbor, MA, USA) and housed under specific pathogen-
free conditions. Mice were used between 5 and 8 weeks 
of age. All animals were bred and maintained at the 
institution’s animal facility of the National Institute for 
Cancer Research, Genoa, Italy.
A cell suspension of SKNBE2_Mock-, SKNBE2-
Anti45A (3x106 cells) in PBS was subcutaneously injected 
into NOD/SCID mice. Ten mice for each cell line were 
divided in 2 groups: i) mice injected with Mock cells 
(n=5); ii) Mice injected with Anti45A-overexpressing 
cells (n=5). Mice were observed weekly for the 
appearance sites: tumor size was measured daily with 
calipers in all groups and tumor volume was calculated 
by the formula length2 × width × π/6. Mice injected s.c. 
were sacrificed when the tumor size reached 2 000 mm3 
or greater. To calculate the tumor development function 
by the polynomial interpolation, we used the average 
of the daily measures when each mouse had the tumor 
mass. For each group the averaged progression rate by 
the linear regression was calculated. In order to detect if 
the expression of Anti-45A transcript (and the consequent 
downregulation of 45RNA expression) persists after the 
injection of cells in mice, we isolated SKNBE2 cells from 
tumor nodules, by Trypsin/Collagenase digestion, and 
measured the 45A expression levels by Real-Time RT-
PCR, confirming the downregulation of the ncRNA (data 
not shown).
Histological analysis
For histological examination, tumors derived 
from each experimental group were surgically removed 
and fixed in 4% neutral-buffered formalin, dehydrated 
and embedded in paraffin using standard histological 
techniques. Serial 5 μm sections were cut and stained 
with Mallory’s trichrome for detection of collagen fibrils 
(deep blue), nuclei and neuroglia fibrils (red). Images were 
captured by transmitted light microscopy using a Zeiss 
Axiovert 200M microscope equipped with a Zeiss Axio-
Cam MRc color chilled 3CCD camera (Zeiss, Wetzlar, 
Germany).
DAB-Immunohistochemical staining and 
quantification
Immunochemistry detection of KI-67 and GTSE1 
was conducted on sections of 4% paraformaldehyde (PFA) 
fixed paraffin-embedded tumors explanted from mice. 
Antigen retrieval was done with 6.0 pH citrate buffer in a 
microwave oven. The sections were immunostained using 
rabbit anti-KI-67 (SP6 NB600-1252 Novus Biologicals), 
anti-GTSE1 (ab103232, Abcam), overnight at 4°C. The 
antibody complex was revealed with Rabbit EnVision+ 
System-Peroxidase (Dako) and Diaminobenzidine 
peroxidase reaction (DAB). The sections were 
counterstained with modified Mayer hematoxylin and 
mounted in Glycerol gel (Dako).
For quantification of DAB-Immunohistochemical 
staining with GTSE1, 8 randomly chosen microscope 
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fields from each SKNBE2-Mock and SKNBE2-Anti45A 
tumor nodule sections were captured at 60x magnification 
and the proportion of GTSE1 positive areas determined 
using ImageJ software. Images were converted in HSB 
and threshold was manually adjusted to localize DAB-
stained areas of interest. The number of pixels within 
the hue range set was determined and expressed as a 
percentage of the total selected area (yellow line).
For KI-67, immunohystochemical staining 
quantification 10 images per sample representing central 
and peripheral tumor areas were acquired using 60X 
objective. The percentage of DAB-stained nuclei of 
the total nuclei (DAB and hematoxylin-stained) was 
calculated using the application, named ImmunoRatio, that 
calculates the percentage of positively stained nuclear area 
(labeling index) by using a color deconvolution algorithm 
for separating the staining components. From 5 SKNBE2-
Mock and 5 SKNBE2-Anti45A samples, 10 images per 
sample representing central and peripheral tumor areas 
were acquired using 60X objective.
Metastatic neuroblastoma mouse model and 
luciferase detection
Mice were purchased from Charles River (CALCO 
Italy) and housed under specific pathogen-free conditions. 
Six-week-old male and female NOD/SCID mice were 
intracardiac injected with pmeLUC-SKNBE2-Mock and 
SKNBE2-Anti45A cells (1x105 cells/mouse). BLI was 
performed evaluating the stably pmeLUC-transfected NB 
cell, by highly sensitive, cooled CCD camera mounted 
in a light-tight specimen box (IVIS; Xenogen, Waltham, 
MA, USA). Tumor growth was assessed weekly by 
bioluminescence imaging. Briefly, 10 min before every 
acquisition, animals were intraperitoneally injected with 
the substrate D-luciferin (Promega, Madison, WI) and 
anesthetized with 1–3% isofluorane (Veterinaria Esteve, 
Alcazar De San Juan, Spain). Mice were then placed 
onto the warmed stage, inside the light-tight camera 
box, with continuous exposure to 1–2% isofluorane. 
Bioluminescence intensity (BLI) is expressed as photons 
per second (p/s).
Evaluation of cell mechanical properties
AFM measurements were performed by using a 
Nanowizard III (JPK Instruments, Germany) mounted 
on an Axio Observer D1 (Carl Zeiss, Germany) inverted 
optical microscope. V-shaped silicon nitride cantilevers 
(NP, Bruker, USA), with a nominal spring constant 
ranging from 0.06 N/m and pyramidal tip with typical 
curvature radius of 20 nm were used. The actual spring 
constant of each cantilever was determined in situ, using 
the thermal noise method [31].
The experiments were performed on living cells, 
working in RPMI 1640 medium (ECB9006L EuroClone), 
10% FBS (DE14-801F, Lonza), L-glutamine (2 mM; 
EuroClone), penicillin–streptomycin (100 U/ml/ 100 μ 
g/ml; EuroClone) (standard medium) and maintaining 
the temperature constant at 37°C. AFM experiments 
were performed in less than 1 h, in order to preserve 
cell viability. Force maps (32x32 Force distance (FD) 
curves) were acquired on small area of 5x5 μm2 on the 
central part of the cell by using the QI mode option 
(JPK Instruments, Germany) that allowed for a fast 
acquisition of a high number of FD curve. The tested 
areas were selected directly on the optical images; the 
exact superimposition between optical images and the 
AFM tip positions was obtained by using the Direct 
Overlay routine of the AFM acquisition software (JPK 
Instruments, Germany). The maximum force applied 
on the sample was 350 pN in all the tested points, FD 
curves length was varying between 1.0 and 1.5 μm, the 
tip velocity maintained constant to 25 μm/s.
FD curves were converted in force vs. tip-sample 
separation curves (FI). The Hertz’s model was used to 
calculate the Young’s (E) modulus of cells. The best fit 
between the experimental data and theoretical model of 
a non-deformable pyramidal indenter provided the value 
of E. The Poisson’s ratio was considered 0.5. Maximal 
indentations of 600 nm were taken in to account by the 
fitting procedure, in order to minimize the effect of the 
presence of a rigid substrate on the result.
Statistical analysis
Results are expressed as mean ± Standard Deviation. 
Statistical significance of observed differences among 
different experimental groups was calculated using a 
two-tailed unpaired Student’s t test. A P value of less than 
0.05 was considered to be statistically significant. In the 
figures, * and ** indicate statistical significance at p < 
0.05 and 0.01, respectively. The statistical calculations 
were performed with GraphPad Prism 6.0 for Windows 
(GraphPad Software, La Jolla, CA, USA).
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